# An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

> **NCT07680166** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Xentria, Inc.** · enrollment: 182 (estimated)

## Conditions studied

- Pulmonary Sarcoidosis

## Interventions

- **DRUG:** XTMAB-16
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07680166
- **Lead sponsor:** Xentria, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2029-10-31
- **Final completion:** 2029-10-31
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2026-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680166, "An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*